Cargando…
Bufalin reverses multidrug resistance by regulating stemness through the CD133/nuclear factor‐κB/MDR1 pathway in colorectal cancer
Recent studies have shown that MDR could be induced by the high stemness of cancer cells. In a previous study, we found bufalin could reverse MDR and inhibit cancer cell stemness in colorectal cancer, but the relationship between them was unclear. Here we identified overexpressing CD133 increases le...
Autores principales: | Zhan, Yueping, Qiu, Yanyan, Wang, Haijing, Wang, Ziyuan, Xu, Jian, Fan, Guohua, Xu, Jianhua, Li, Wei, Cao, Yijun, Le, Van‐Minh, Ly, Hai‐Trieu, Yuan, Zeting, Xu, Ke, Yin, Peihao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226280/ https://www.ncbi.nlm.nih.gov/pubmed/32058643 http://dx.doi.org/10.1111/cas.14345 |
Ejemplares similares
-
Targeting CD133 reverses drug-resistance via the AKT/NF-κB/MDR1 pathway in colorectal cancer
por: Yuan, Zeting, et al.
Publicado: (2020) -
Bufalin suppresses tumour microenvironment-mediated angiogenesis by inhibiting the STAT3 signalling pathway
por: Fang, Kai, et al.
Publicado: (2021) -
Bufalin reverses acquired drug resistance by inhibiting stemness in colorectal cancer cells
por: Sun, Jian, et al.
Publicado: (2017) -
Bufalin-loaded vitamin E succinate-grafted-chitosan oligosaccharide/RGD conjugated TPGS mixed micelles demonstrated improved antitumor activity against drug-resistant colon cancer
por: Yuan, Zeting, et al.
Publicado: (2018) -
Effects of bufalin on the mTOR/p70S6K pathway and apoptosis in esophageal squamous cell carcinoma in nude mice
por: Liu, Yao, et al.
Publicado: (2017)